Proposed Data Collections Submitted for Public Comment and Recommendations, 70355-70356 [E8-27619]
Download as PDF
<![CDATA[
70355
Federal Register / Vol. 73, No. 225 / Thursday, November 20, 2008 / Notices
including metropolitan Atlanta. Control
infants are randomly selected from birth
certificates or birth hospital records.
Mothers of case and control infants are
interviewed using a computer-assisted
telephone interview. The interview is
estimated to take one hour. A maximum
of thirty-six hundred interviews are
planned, 2,700 cases and 900 controls,
resulting in a maximum interview
burden of 3,600 hours for all Centers.
Parents are also asked to collect cheek
cells from themselves and their infants
for DNA testing. The collection of cheek
cells by the mother, father, and infant is
estimated to take about 10 minutes per
person. Each person will be asked to rub
1 brush inside the left cheek and 1
brush inside the right cheek for a total
of 2 brushes per person. Collection of
the cheek cells takes approximately 1–
2 minutes, but the estimate of burden is
10 minutes to account for reading and
understanding the consent form and
specimen collection instructions and
mailing back the completed kits. The
anticipated maximum burden for
collection of the cheek cells is 1,800
hours.
Information gathered from both the
interviews and the DNA specimens will
be used to study independent genetic
and environmental factors as well as
gene-environment interactions for a
broad range of carefully classified birth
defects.
There are no costs to the respondents
other than their time. The total
estimated annualized burden is 5,400
hours.
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents
Respondents
NBDPS case/control interview .....................................................................................................
Biologic Specimen Collection ......................................................................................................
Dated: November 13, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–27618 Filed 11–19–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–09–09AE]
rwilkins on PROD1PC63 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
VerDate Aug<31>2005
18:26 Nov 19, 2008
Jkt 217001
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Chagas Disease knowledge, attitude,
practices (KAP) study of physicians—
New—Coordinating Center for
Infectious Disease (CCID), National
Center for Zoonotic, Vector-borne, and
Enteric Diseases (NCZVED), Division of
Parasitic Diseases (DPD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Division of Parasitic Diseases is
proposing a knowledge, attitudes, and
practices (KAP) study to determine the
level of physician awareness and
understanding of Chagas disease.
Chagas disease is a blood-borne
parasitic disease, found only in the
Americas, and spread through contact
with the triatomine bug. Chagas disease
can also be contracted through blood
transfusion, organ transplantation, and
from mother to child congenitally. This
disease is not spread through person-toperson contact. Chagas disease can
cause serious heart and stomach illness;
for some patients, treatment with
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
3,600
10,800
1
1
Avg. burden
per response
(In hours)
1
10/60
antiparasitic medications prevents these
serious complications and may
eliminate the infection. The hypothesis
of this research study is that there will
be a dramatic Chagas disease knowledge
deficit among physicians. In the first 20
months of blood donor screening for
Chagas disease, at least 624 positive
blood donors were identified. Currently,
only about 10% of blood donors with
Chagas disease are receiving treatment
medication. It is suspected that most
physicians are not familiar with this
disease and this may negatively impact
patient care: (1) When positive blood
donors see their healthcare provider, (2)
when organs and tissues are
transplanted unknowingly from infected
donors, and (3) when infected mothers
give birth to babies without screening
for Chagas disease. This KAP study will
survey physicians in areas where there
may be more patients with Chagas
disease. The survey will be sent to all
physician members of several partner
organizations. Results will be analyzed
in order to develop physician education
material. That material will then be sent
to all members. Subsequently, a second
follow-up survey, very similar to the
initial one, will be sent in order to
determine levels of knowledge change.
The data collected by this study will
allow DPD to understand, and
consequently develop and appropriately
target medical educational material to
address, Chagas disease knowledge
deficits of physicians.
There is no cost to respondents other
than their time.
E:\FR\FM\20NON1.SGM
20NON1
70356
Federal Register / Vol. 73, No. 225 / Thursday, November 20, 2008 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Physicians ........................................................................................................
Dated: November 14, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–27619 Filed 11–19–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
rwilkins on PROD1PC63 with NOTICES
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel Site Visit (Stanford University).
Date: December 12, 2008.
Time: 8 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Suite 4076, Bethesda, MD
20892.
Contact Person: Keith McKenney, PhD,
Scientific Review Officer, NHGRI, 5635
Fishers Lane, Suite 4076, Bethesda, MD
20814, 301–594–4280,
mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: November 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–27382 Filed 11–19–08; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
18:26 Nov 19, 2008
Jkt 217001
300
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Targeted Clinical Trials to
Reduce the Risk of Antimicrobial Resistance.
Date: December 15, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Crowne Plaza—Silver Spring, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Lynn Rust, PhD, Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, National
Institutes of Health/NIAID, 6700B Rockledge
Drive, MSC 7616, Bethesda, MD 20892, 301–
402–3938, lr228v@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Targeted Clinical Trials to
Reduce the Risk of Antimicrobial Resistance.
Date: December 16, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Crowne Plaza—Silver Spring, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Lynn Rust, PhD, Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, National
Institutes of Health/NIAID, 6700B Rockledge
Drive, MSC 7616, Bethesda, MD 20892, 301–
402–3938, lr228v@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
2
Total burden
(in hours)
3/60
30
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 13, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–27531 Filed 11–19–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of Biotechnology Activities,
Office of Science Policy, Office of the
Director; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
National Science Advisory Board for
Biosecurity (NSABB). Under authority
42 U.S.C. 217a, Section 222 of the
Public Health Service Act, as amended,
the Department of Health and Human
Services established NSABB to provide
advice, guidance and leadership
regarding federal oversight of dual use
research, defined as biological research
with legitimate scientific purposes that
could be misused to pose a biological
threat to public health and/or national
security.
The meeting will be open to the
public, however pre-registration is
strongly recommended due to space
limitations. Persons planning to attend
should register online at
www.biosecurityboard.gov/
meetings.asp or by calling Capital
Consulting Corporation (Contact:
Saundra Bromberg at 301–468–6004,
ext. 406). Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
indicate these requirements upon
registration.
Name of Committee: National Science
Advisory Board for Biosecurity
Date: December 10, 2008
Open: 8:30 a.m. to 6 p.m.
Agenda: Presentations and discussions
regarding: (1) Preliminary findings and
recommendations on strategies to optimize
programs of personnel reliability for
individuals with access to select agents and
toxins; (2) brief overview of Public
E:\FR\FM\20NON1.SGM
20NON1
]]>Agencies
[Federal Register Volume 73, Number 225 (Thursday, November 20, 2008)]
[Notices]
[Pages 70355-70356]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-27619]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-09-09AE]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Chagas Disease knowledge, attitude, practices (KAP) study of
physicians--New--Coordinating Center for Infectious Disease (CCID),
National Center for Zoonotic, Vector-borne, and Enteric Diseases
(NCZVED), Division of Parasitic Diseases (DPD), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Division of Parasitic Diseases is proposing a knowledge,
attitudes, and practices (KAP) study to determine the level of
physician awareness and understanding of Chagas disease. Chagas disease
is a blood-borne parasitic disease, found only in the Americas, and
spread through contact with the triatomine bug. Chagas disease can also
be contracted through blood transfusion, organ transplantation, and
from mother to child congenitally. This disease is not spread through
person-to-person contact. Chagas disease can cause serious heart and
stomach illness; for some patients, treatment with antiparasitic
medications prevents these serious complications and may eliminate the
infection. The hypothesis of this research study is that there will be
a dramatic Chagas disease knowledge deficit among physicians. In the
first 20 months of blood donor screening for Chagas disease, at least
624 positive blood donors were identified. Currently, only about 10% of
blood donors with Chagas disease are receiving treatment medication. It
is suspected that most physicians are not familiar with this disease
and this may negatively impact patient care: (1) When positive blood
donors see their healthcare provider, (2) when organs and tissues are
transplanted unknowingly from infected donors, and (3) when infected
mothers give birth to babies without screening for Chagas disease. This
KAP study will survey physicians in areas where there may be more
patients with Chagas disease. The survey will be sent to all physician
members of several partner organizations. Results will be analyzed in
order to develop physician education material. That material will then
be sent to all members. Subsequently, a second follow-up survey, very
similar to the initial one, will be sent in order to determine levels
of knowledge change. The data collected by this study will allow DPD to
understand, and consequently develop and appropriately target medical
educational material to address, Chagas disease knowledge deficits of
physicians.
There is no cost to respondents other than their time.
[[Page 70356]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Physicians...................................... 300 2 3/60 30
----------------------------------------------------------------------------------------------------------------
Dated: November 14, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E8-27619 Filed 11-19-08; 8:45 am]
BILLING CODE 4163-18-P
